Boughanem, H.; Martin-Nuñez, G.M.; Torres, E.; Arranz-Salas, I.; Alcaide, J.; Morcillo, S.; Tinahones, F.J.; Crujeiras, A.B.; Macias-Gonzalez, M.
Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival. J. Pers. Med. 2020, 10, 219.
https://doi.org/10.3390/jpm10040219
AMA Style
Boughanem H, Martin-Nuñez GM, Torres E, Arranz-Salas I, Alcaide J, Morcillo S, Tinahones FJ, Crujeiras AB, Macias-Gonzalez M.
Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival. Journal of Personalized Medicine. 2020; 10(4):219.
https://doi.org/10.3390/jpm10040219
Chicago/Turabian Style
Boughanem, Hatim, Gracia María Martin-Nuñez, Esperanza Torres, Isabel Arranz-Salas, Julia Alcaide, Sonsoles Morcillo, Francisco J Tinahones, Ana B Crujeiras, and Manuel Macias-Gonzalez.
2020. "Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival" Journal of Personalized Medicine 10, no. 4: 219.
https://doi.org/10.3390/jpm10040219
APA Style
Boughanem, H., Martin-Nuñez, G. M., Torres, E., Arranz-Salas, I., Alcaide, J., Morcillo, S., Tinahones, F. J., Crujeiras, A. B., & Macias-Gonzalez, M.
(2020). Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival. Journal of Personalized Medicine, 10(4), 219.
https://doi.org/10.3390/jpm10040219
